Search Results 871-880 of 17599 for Assay

1. A Study To Assess The Effectiveness And Safety Of Pacritinib In Patients With VEXAS Syndrome (PAXIS) - Mayo Clinic

   Positive Quantiferon (or other interferon gamma release assay) during Screening. Note: patients with indeterminant Quantiferon results may enroll. Known ...

2. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

   Known PD-L1 tumor status as determined by an IHC assay performed by a central laboratory on previously obtained archival tumor tissue or tissue obtained from a ...

3. A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations - Mayo Clinic

   ... assay (e.g., FoundationOne® CDx or Guardant360® CDx), breakapart fluorescence in situ hybridization (FISH), or other validated assay. Potential participants ...

4. A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 75 Years of Age With Thyroid Eye Disease - Mayo Clinic

   ... assay method) and laboratory reference ranges. Additional inclusion criteria are defined in the study protocol. Exclusion Criteria: * Anticipated need for ...

5. Induction Therapy With RO7790121 in Patients With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

   ... assay (ELISA) tests (e.g., T-SPOT® ), with the following exceptions: – Potential participants with a history of Bacillus Calmette-Guérin (BCG) vaccination ...

6. A Study To Evaluate Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderately To Severely Active Ulcerative Colitis (MK-7240-001) - Mayo Clinic

   Note: If the QuantiFERON-TB test is indeterminate, a second test should be performed through the central laboratory or local TB interferon gamma release assay ...

7. Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid - Mayo Clinic

   Positive Anti-Mitochondrial Antibodies (AMA) titers (> 1/40 on immunofluorescence or M2 positive by enzyme-linked immunosorbent assay (ELISA); Liver biopsy ...

8. Publications - Shounak Majumder, M.D. - Mayo Clinic

   High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9. Clin Cancer Res. 2021 May 1; 27 (9):2523 ...

9. Phase 2b Study of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis - Mayo Clinic

   Positive, indeterminate, or invalid interferon-gamma release assay test result at Screening, unless previously treated for TB. Participants with an ...

10. Emergency Care Clinical Trials - Mayo Clinic Research

    ... assays (which occurs in July 2018), in the midst of our study period. A Study to Evaluate Droperidol Use in the Emergency Department and the Effect on QTc ...